Sort   by:  
 Page size 
ProteomicsCD209L/L-SIGN N-Glycosylation and N-Glycosylation Site Occupancy
CD209L is a membrane glycoprotein with known glycan-binding properties and it also contains 2 N-glycosylation sequons at sites N92 and N361. Treatment with PNGase F in the presence of H218O, which removes N-linked glycans and isotopically labels the formerly-glycosylated site, confirmed that both un...
ORGANISM(S): Homo sapiens (Human) 
2021-09-09 | PXD021309 | Pride
Human cd209l Dc-sign N-glycosylation 
UnknownThe heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region.
Not available
S-EPMC1271393 | biostudies-literature
UnknownCD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.
Not available
S-EPMC524836 | biostudies-literature
UnknownCD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2.
Not available
S-EPMC7325172 | biostudies-literature
UnknownCD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.
Not available
S-EPMC8265543 | biostudies-literature
UnknownThe evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates.
Not available
S-EPMC2701223 | biostudies-literature
UnknownA novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung.
Not available
S-EPMC2118498 | biostudies-literature
UnknownDC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.
Not available
S-EPMC4988148 | biostudies-literature
UnknownHuman cell receptors: potential drug targets to combat COVID-19.
Not available
S-EPMC8097256 | biostudies-literature
UnknownNovel member of the CD209 (DC-SIGN) gene family in primates.
Not available
S-EPMC140574 | biostudies-literature
Sort   by:  
 Page size